Document is current
Any future updates will be listed below
-
Authors
Hickerson, Brady T.
Daniels-Wells, Tracy R. https://orcid.org/0000-0002-8277-9702
Payes, Cristian
Clark, Lars E. https://orcid.org/0000-0002-6093-7597
Candelaria, Pierre V.
Bailey, Kevin W.
Sefing, Eric J.
Zink, Samantha https://orcid.org/0000-0002-3220-8290
Ziegenbein, James
Abraham, Jonathan https://orcid.org/0000-0002-7937-3920
Helguera, Gustavo https://orcid.org/0000-0003-1509-3564
Penichet, Manuel L.
Gowen, Brian B. https://orcid.org/0000-0001-9113-2575
-
Funding
Funding for this research was provided by:
Fundación René Barón
Programa Bec.Ar Fundacion Bunge y Born Fundacion Williams
U.S. Department of Health & Human Services | National Institutes of Health (R01CA196266, R21AI135851)
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 15 May 2020
Accepted: 22 December 2021
First Online: 28 January 2022
Competing interests
: Dr. Manuel Penichet has a financial interest in Stellar Biosciences, Inc. The Regents of the University of California are in discussions with Stellar Biosciences to license a technology invented by Dr. Penichet to this firm. In addition, Dr. Penichet has a financial interest in Klyss Biotech, Inc. All other authors declare no competing interests.
: All animal procedures complied with USDA guidelines and were conducted at the AAALAC-accredited laboratory animal research facilities at Utah State University under protocol #10034, approved by the Utah State University Institutional Animal Care and Use Committee.
